Ftse Mib
36.016,80
-0,35%
DAX
21.008,11
0,02%
S&P 500
6.019,44
0,38%
NASDAQ
19.630,20
0,00%
Bitcoin
103.587,04
1,53%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nexalin Technologies Inc (NXLIW) Nexalin Technologies Inc (NXLIW) Notizie

NXLIW

Nexalin Technologies (NXLIW)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NXLIW
DataOraFonteTitoloSimboloCompagnia
14/01/202514:30GlobeNewswire Inc.Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025NASDAQ:NXLIWNexalin Technologies Inc
10/01/202522:35Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NXLIWNexalin Technologies Inc
23/12/202416:00GlobeNewswire Inc.Nexalin Technology Completes Phase 1of its Innovative Virtual ClinicNASDAQ:NXLIWNexalin Technologies Inc
20/12/202418:35Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NXLIWNexalin Technologies Inc
26/11/202416:00GlobeNewswire Inc.New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation MarketNASDAQ:NXLIWNexalin Technologies Inc
11/11/202414:00GlobeNewswire Inc.Nexalin Technology CEO Provides Letter to ShareholdersNASDAQ:NXLIWNexalin Technologies Inc
08/11/202422:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLIWNexalin Technologies Inc
01/11/202419:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLIWNexalin Technologies Inc
01/11/202419:00GlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5thNASDAQ:NXLIWNexalin Technologies Inc
01/11/202415:34GlobeNewswire Inc.Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NXLIWNexalin Technologies Inc
30/10/202415:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLIWNexalin Technologies Inc
28/10/202413:30GlobeNewswire Inc.Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's DiseaseNASDAQ:NXLIWNexalin Technologies Inc
22/10/202420:15GlobeNewswire Inc.Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VANASDAQ:NXLIWNexalin Technologies Inc
17/10/202414:30GlobeNewswire Inc.New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s PatientsNASDAQ:NXLIWNexalin Technologies Inc
14/10/202414:30GlobeNewswire Inc.Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory AffairsNASDAQ:NXLIWNexalin Technologies Inc
05/09/202415:00GlobeNewswire Inc.Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid TreatmentNASDAQ:NXLIWNexalin Technologies Inc
18/07/202414:30GlobeNewswire Inc.Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use RecoveryNASDAQ:NXLIWNexalin Technologies Inc
01/07/202420:45GlobeNewswire Inc.Nexalin Technology Announces Closing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
28/06/202403:15GlobeNewswire Inc.Nexalin Technology Announces Pricing of $5.2 Million Public OfferingNASDAQ:NXLIWNexalin Technologies Inc
26/06/202415:00GlobeNewswire Inc.Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific JournalNASDAQ:NXLIWNexalin Technologies Inc
20/06/202414:30GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and DementiaNASDAQ:NXLIWNexalin Technologies Inc
13/06/202421:00GlobeNewswire Inc.Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)NASDAQ:NXLIWNexalin Technologies Inc
04/06/202414:30GlobeNewswire Inc.Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6thNASDAQ:NXLIWNexalin Technologies Inc
03/06/202414:30GlobeNewswire Inc.FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset DeviceNASDAQ:NXLIWNexalin Technologies Inc
22/05/202414:30GlobeNewswire Inc.Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research EffortsNASDAQ:NXLIWNexalin Technologies Inc
14/05/202422:54Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:NXLIWNexalin Technologies Inc
09/05/202414:30GlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23NASDAQ:NXLIWNexalin Technologies Inc
09/04/202414:30GlobeNewswire Inc.Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical TestingNASDAQ:NXLIWNexalin Technologies Inc
04/04/202419:00GlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation DeviceNASDAQ:NXLIWNexalin Technologies Inc
02/04/202414:30GlobeNewswire Inc.Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory BoardNASDAQ:NXLIWNexalin Technologies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NXLIW

La tua Cronologia

AQSE
AEP.GB
Anglo Eastern Plantations
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network